TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - MERCK & CO. Stock

Certificat

DE000SD7RE33

Market Closed - Deutsche Boerse AG 03:45:40 2024-07-11 pm EDT
6.8 EUR +1.80% Intraday chart for TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - MERCK & CO.
Current month-0.73%
1 month-5.69%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-11 6.8 +1.80%
24-07-10 6.68 +0.91%
24-07-09 6.62 +0.61%
24-07-08 6.58 -0.90%
24-07-05 6.64 +1.37%

Delayed Quote Deutsche Boerse AG

Last update July 11, 2024 at 03:45 pm EDT

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer Société Générale Société Générale
WKN SD7RE3
ISINDE000SD7RE33
Date issued 2021-04-30
Strike 54.7 $
Maturity Unlimited
Parity 10 : 1
Emission price 1.97
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 7.44
Lowest since issue 1.97

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
129 USD
Average target price
142.6 USD
Spread / Average Target
+10.54%
Consensus